{
  "pmcid": "7807392",
  "sha256": "13ab16e6dc8d8ab7f46dcc9f3d12ef1e86afbfc39d005a2e6b730313e02f5a86",
  "timestamp_utc": "2025-11-10T00:07:21.394718+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.73046722907203,
    "reading_ease": 24.545356911096718,
    "word_count": 268
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Postdischarge Video-Based Virtual Visits vs. In-Person Follow-Up"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomised, active, controlled noninferiority trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients from a small community hospital and a large tertiary care hospital. Participants included those undergoing minimally invasive appendectomy or cholecystectomy."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomisation was performed in a 2:1 ratio to either video-based virtual visits or in-person visits"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to assess the noninferiority of virtual visits compared to in-person follow-up in terms of 30-day hospital encounter rates."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the percentage of patients experiencing a 30-day hospital encounter"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "using a computer-generated sequence with concealed allocation"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not applicable."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "432 were randomised, with 289 assigned to the virtual group and 143 to the in-person group"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis followed an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The hospital encounter rate was noninferior for virtual visits (12.8% vs. 13.3% for in-person, Δ 0.5% with 1-sided 95% CI, −∞ to 5.2%)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported in either group."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov Identifier: NCT03258177"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 20,
    "max_score": 25
  }
}